Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy

NCT04571216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation
Nicotine Dependence

Interventions

DRUG: NFL-101 dose 1
DRUG: NFL-101 dose 2
DRUG: Placebo

Sponsor

NFL Biosciences SAS